|
|
|
|
|
|||||||
|
Session 67
Poster Session
Disease Progression/Effects of Treatment 4:30-6:30 pm 4E-F |
to view the poster for an abstract.| 473-M. | Factors Associated with Immunologic Stage at which Patients Initiate Antiretroviral Therapy A. McNaghten*, D. L. Hanson, S. Kellerman, and J. Blair for the Adult/Adolescent Spectrum of HIV Disease Project CDC, Atlanta, GA
| ||
| 474-M. | Frequency and Predictors of Late HIV Diagnosis in the United States, 1994 through 1999 J. J. Neal* and P. L. Fleming CDC, Atlanta, GA
| ||
| 475-M. | Initial CD4+ T-Cell Counts in Patients with Newly Diagnosed HIV Infection Indicate that a Substantial Proportion of these Patients Have Advanced Disease Regardless of Gender, Race, or Socio-Economic Status M. Dybul*1, R. Bolan2, D. Condoluci3, R. Cox-Iyamu4, R. Redfield5, C. Hallahan1, K. Sathasivam4, M. Folino3, M. Weisberg2, M. Andrews3, B. Hidalgo1, J. Vasquez1, and A. S. Fauci1 1NIAID, NIH, Bethesda, MD; 2Jeffrey Goodman Special Care Program, Glendale, CA; 3Garden State Infectious Disease Associates, Voorhes, NJ; 4Whitman Walker Clin., Washington, DC; and 5Inst. of Human Virology, Baltimore, MD
| ||
| 476-M. | Changes in both CD4 Cell Counts and HIV-1 RNA Levels Predict Subsequent Disease Progression among HIV-1-Infected Persons Initiating Antiretroviral Therapy R. Hogg*, B. Yip, K. Chan, E. Wood, P. R. Harrigan, K. Craib, M. V. O'Shaughnessy, and J. S. G. Montaner BC Ctr. for Excellence in HIV/AIDS and the Univ. of British Columbia, Vancouver, Canada;
| ||
| 477-M. | Recent Trends in Treatment Use and Virological Suppression in a London HIV Clinic Population F. Lampe*, M. A. Johnson, C. Loveday, C. Chaloner, C. Sabin, M. Youle, S. Kinloch, S. Madge, and A. N. Phillips Royal Free Centre for HIV Med., London, UK
| ||
| 478-M. | Short-Term Toxicity and Discontinuation of Antiretroviral Post-Exposure Prophylaxis V. Puro*, G. De Carli, F. Mattioli, Z. Mariano and G. Ippolito INMI Spallanzani, Rome, Italy
|
